University of Thessaly (UTH)
Χρόνια αποφρακτική πνευμονοπάθεια: μελέτη κλινικών, λειτουργικών και βιοχημικών παραμέτρων στις παροξύνσεις ΧΑΠ
Abstract
dc:descriptionThe pathways underlying chronic obstructive pulmonary disease exacerbations (ECOPD) remain unclear. This study describes the clinical, functional and biochemical changes during recovery from ECOPD. Thirty hospitalized patients with Anthonisen's type-I ECOPD were evaluated on days 0 (admission), 3, 10 and 40. A five symptom score (TSS), performance status and quality of life were evaluated. Post-bronchodilator spirometry, blood gases, oxidative stress, C-reactive protein (CRP), serum amyloid-A (SAA), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and fibrinogen were also measured. Patients were classified as early- or late-recoverers, based on whether dyspnea had returned to pre-exacerbation level by day 10. Most clinical, functional and biochemical parameters improved during follow-up. CRP and IL-6 levels were reduced on Day 3 (p<0.05), whereas SAA on Day 10 (p<0.01). TNF-α was reduced on Days 3 and 10, but on Day 40 its levels returned to baseline. Fibrinogen and WBC decreased significantly only by day 40. TSS and dyspnea correlated inversely with FEV1 on days 3, 10 and 40. Although late-recoverers had lower FEV1 on admission, none of the reported measurements on admission and on day 3 predicted early recovery. In conclusion, we have shown that ECOPD are characterized by prolonged recovery periods during which symptomatic improvement (and particularly dyspnea decline) coincides with lung function amelioration and inflammatory burden subsidence, but directly correlates only to post-bronchodilator FEV1. Although, early symptomatic recovery can not be predicted based on single time-point assessments, follow-up measurements may assure uneventful recovery. In this context, it has been shown that simple spirometry is feasible in the majority of hospitalized patients with ECOPD and may provide useful information for the follow-up and outcome of these patients, whereas changing patterns of certain biomarkers (especially CRP, SAA, TNF-α, IL-6 and fibrinogen) may provide an insight into the underlying pathways of ECOPD.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Κουτσοκέρα, Αγγέλα
- Koutsokera, Aggeliki
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/17128